Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03452072 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds
A Phase 2 study of Wound Heal and Surgical Wound, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT03452072 is a Phase 2 study of Wound Heal and Surgical Wound that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 88 participants, below the 116-participant average among 23 other Wound Heal trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03452072, a Phase 2 study of Wound Heal and Surgical Wound, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
The use of topical beta-blockers, such as 0.25% timolol, in promoting wound healing is currently emerging in the academic literature. The investigators will enroll 114 patients who have their skin cancer surgically removed resulting in open surgical wounds less or equal to 1.5 cm. The objective of this randomized safety study is to determine the safety and efficacy of 0.25% timolol in promoting wound healing in open surgical wounds less or equal to 1.5 cm.
Conditions Studied
Interventions
- DRUG 0.25% Timolol gel with paraffin gauze dressings
- OTHER Vaseline dressing
Study Locations (1)
Massachusetts
- Mohs and Dermatologic Surgery Center, Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2018-08-20 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03452072
The ClinicalTrials.gov registry entry for NCT03452072 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 23 other Wound Heal trials with a reported enrollment target (24% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Wound Heal appearing as the primary indexed condition, and to 2 interventions - of which 0.25% Timolol gel with paraffin gauze dressings is the first listed.
NCT03452072 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03452072 about?
NCT03452072 is a clinical study titled "Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds". The use of topical beta-blockers, such as 0.25% timolol, in promoting wound healing is currently emerging in the academic literature. The investigators will enroll 114 patients who have their skin cancer surgically removed resulting in open surgical wounds less or equal to 1.5 cm. The objective of t...
What is the current status of trial NCT03452072?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2018-08-20. Estimated completion is 2021-06-30.
What conditions does trial NCT03452072 study?
This clinical trial studies the following conditions: Wound Heal, Surgical Wound, Wound of Skin, Wound Open.
What interventions are being tested in trial NCT03452072?
The interventions under investigation include: 0.25% Timolol gel with paraffin gauze dressings (DRUG), Vaseline dressing (OTHER).
Who is sponsoring clinical trial NCT03452072?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03452072 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Heal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
4-aminopyridine for Skin Wound Healing
RECRUITING · Phase 2
-
Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)
RECRUITING · Phase 2
-
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
COMPLETED · Phase 2
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Dermabrasion in Mohs: Split-Scar Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.